Cargando…
What if a tumor is significantly enlarged just before stereotactic body radiation therapy? A case report and review of the literature
Stereotactic body radiation therapy (SBRT) plays an important role in early stage non‐small cell lung cancer. Tumor growth before radiotherapy planning (RTP) or during SBRT has been reported in lung cancer patients; however, little is known of growth during the period in‐between (i.e. after RTP but...
Autores principales: | Chen, Hung‐Jen, Liang, Ji‐An, Chen, Chih‐Yi, Yu, Yang‐Hao, Chien, Chun‐Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334306/ https://www.ncbi.nlm.nih.gov/pubmed/28102933 http://dx.doi.org/10.1111/1759-7714.12405 |
Ejemplares similares
-
Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015) -
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma
por: Yang, Jen-Fu, et al.
Publicado: (2022) -
Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma
por: Jun, Baek Gyu, et al.
Publicado: (2018) -
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
por: Maksoud, Ziad, et al.
Publicado: (2022) -
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series
por: Wang, Ying-Fu, et al.
Publicado: (2021)